Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Location » West Virginia

Morgantown, West Virginia Clinical Trials

Acute Myelogenous Leukemia (AML)

West Virginia University - Clinical Trials Research Unit

BMTCTN0901: A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Aneurysm

West Virginia University Hospital

A Phase 4 clinical study for patients with Intracranial Aneurysms

West Virginia University Hospital

A clinical research study of Coil Embolization with larger Diameter Coils and Coil Embolization with Standard Diameter Coils for the treatment of Cerebral Aneurysm

Asthma

GSK Investigational Site

A Phase 4 clinical study for patients with Asthma

Atherosclerosis

West Virginia University

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Blood Cancer

Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Bone Diseases

West Virginia University - Clinical Trials Research Unit

20090482: A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma.

View More »

Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Bone Metastases

Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Breast Cancer

West Virginia University - Clinical Trials Research Unit

A011104 Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

West Virginia University - Clinical Trials Research Unit

S1207 - Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy

West Virginia University - Clinical Trials Research Unit

NSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

West Virginia University - Clinical Trials Research Unit

A011202 - A Randomized Phase III Trial Evaluating The Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

West Virginia University - Clinical Trials Research Unit

ECOG5508 - Randomized Phase III Study of Maintenance Therapy with Bevacizumab,Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

West Virginia University - Clinical Trials Research Unit

NSABP-B47 - A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer

West Virginia University - Clinical Trials Research Unit

NSABP-B51/RTOG-1304 - A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

West Virginia University - Clinical Trials Research Unit

NSABP-B52 - A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated with Neoadjuvant Therapy of Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab (TCHP) With or Without Estrogen Deprivation

View More »

Research Site

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

West Virginia University/ Mary Babb Randolph Cancer Center Dept of Oncology

A clinical trial seeking patients for a research study for the treatment of Breast Cancer

Chronic Lymphocytic Leukemia

West Virginia University - Clinical Trials Research Unit

E1912 - A Randomized Phase III Study of Ibrutinib based Therapy Versus Standard Fludarabine, Cyclophosphamide and Rituxan Chemoimmunotherapy in Untreated Younger Patients with CLL

West Virginia University - Clinical Trials Research Unit

A041202 - A Randomized Phase III Study of Bendamustine Plus Rituximab versus ibrutinib Plus Rituximab versus Ibrutinib Alone in Untreated Older Patients (greater than or equal to 65 years of age with Chronic Lymphocytic Leukemia

View More »

West Virginia University

A Phase 2 clinical study for patients using Plerixafor

Colon Cancer

West Virginia University - Clinical Trials Research Unit

STX0112: Assessment of Overall Survival of FOLFOX6m plus SIR-Spheres microspheres versus FOLFOX6m alone as first-line treatment in patients with non-resectable liver metastases from primary colorectal carcinoma in a randomised clinical study

Colorectal Cancer

West Virginia University - Clinical Trials Research Unit

2012-PT023 - A Pivotal Phase III Study to Evaluate Overall Survival using MABp1 as a Monotherapy in Metastatic Colorectal Cancer Patients with Cachexia

Congenital Heart Disease

West Virginia University Department of Pediatrics

Patients are needed to participate in a clinical research study evaluating observational for the treatment of Pulmonary Arterial Hypertension or Congenital Heart Disease

COPD (Chronic Obstructive Pulmonary Disease)

1237.26.10601 Boehringer Ingelheim Investigational Site Updated

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Forest Investigative Site 3682

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Crohn's Disease

United BioSource Corporation

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Crohn's Disease

Cystic Fibrosis

Site Reference ID/Investigator# 78953

A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis

West Virginia University Research Corporation

Patients are needed to participate in a clinical research study evaluating Burlulipase and Placebo (Caramel in sterile water)

Deep Vein Thrombosis

West Virginia University Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Diabetes Mellitus, Type 2

Gastroenteritis

Site Reference ID/Investigator# 123082 Updated

A clinical study for patients with Ulcerative Colitis

Genitourinary Cancer

West Virginia University - Clinical Trials Research Unit

CALGB90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Transitional Cell Carcinoma

Glioblastoma multiforme

West Virginia University - Clinical Trials Research Unit

A221101 - A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients with Glioblastoma Multiforme

Gliomas

West Virginia University - Clinical Trials Research Unit

RTOG-0834 - Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma: The CATNON Intergroup Trial

Head and Neck Cancer

West Virginia University - Clinical Trials Research Unit

RTOG-0920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

West Virginia University - Clinical Trials Research Unit

RTOG-1016 Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

West Virginia University - Clinical Trials Research Unit

ECOG1305 - A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer

Heart Disease

West Virginia University Department of Pediatrics

Patients are needed to participate in a clinical research study evaluating observational for the treatment of Pulmonary Arterial Hypertension or Congenital Heart Disease

Hematologic Cancer

West Virginia University - Clinical Trials Research Unit

BMTCTN1101: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (haplo-BM) for Patients with Hematologic Malignancies

Hematologic Neoplasms

Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hematological Disorders

West Virginia University - Clinical Trials Research Unit

WVU011012 - Phase II study of Atorvastatin, micro-dose methotrexate and tacrolimus administered only to transplant recipients for the prophylaxis of acute graft-versus-host disease following matched sibling hematopoietic cell transplantation

West Virginia University - Clinical Trials Research Unit

09-PLEX - Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies

West Virginia University - Clinical Trials Research Unit

WVU11310-Once daily intravenous Busulfex as part of reduced toxicity conditioning for patients with relapsed/refractory Hodgkin and non-Hodgkin lymphomas undergoing allogeneic hematopoietic cell transplantation - A multicenter phase II study.

Hepatitis

Research Site

A clinical trial to evaluate treatments using SOF and RBV for patients with Hepatitis C Virus Infection

High Blood Pressure (Hypertension)

West Virginia University Department of Pediatrics

Patients are needed to participate in a clinical research study evaluating observational for the treatment of Pulmonary Arterial Hypertension or Congenital Heart Disease

Hodgkin's Disease

West Virginia University

A Phase 2 clinical study for patients using Plerixafor

Kidney Cancer

West Virginia University - Clinical Trials Research Unit

ECOG1808-A Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features

Kidney Disease

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes or Chronic Kidney Disease

Site Reference ID/Investigator# 105201 Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Leukemia

West Virginia University - Clinical Trials Research Unit

E2906- Phase III trial of Clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed Acute Myeloid Leukemia in older adults (age greater than or equal to 60 years)

West Virginia University - Clinical Trials Research Unit

B1931022 - An Open-label, Randomized Phase 3 Study of Inotuzumab Ozogamicin Compared to a Defined Investigator's Choice in Adult Patients with Relapsed or Refractory CD22-Positive Acute Lymphoblastic Leukemia (ALL)

West Virginia University - Clinical Trials Research Unit

BMTCTN1101: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (haplo-BM) for Patients with Hematologic Malignancies

West Virginia University - Clinical Trials Research Unit

CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia

View More »

Pfizer Investigational Site

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Research Site

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia (CLL)

West Virginia University

A Phase 2 clinical study for patients using Plerixafor

West Virginia University Mary Babb Randolf Cancer Center

Patients are needed to participate in a clinical research study evaluating SNS01-T

Liver Cancer

West Virginia University - Clinical Trials Research Unit

E1208 - A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion

West Virginia University - Clinical Trials Research Unit

DEFIBROTIDE2006-05 -Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study (Under CRF 312.34)

Liver Metastases

West Virginia University Healthcare

A Phase 3 clinical study for patients with Colorectal Cancer Metastatic

Lung Disease

1237.26.10601 Boehringer Ingelheim Investigational Site Updated

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Forest Investigative Site 3682

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

West Virginia University Research Corporation

Patients are needed to participate in a clinical research study evaluating Burlulipase and Placebo (Caramel in sterile water)

Lymphoma

West Virginia University - Clinical Trials Research Unit

C25003: A Randomized, Open-Label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

View More »

GSK Investigational Site

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

Mary Babb Randolph Cancer Center

A clinical trial seeking patients for a research study for the treatment of Relapsed Peripheral T-Cell Lymphoma or Refractory Peripheral T-Cell Lymphoma

Research Site

Patients are needed to participate in a clinical research study to evaluate Diffuse Large B-Cell Lymphoma (DLBCL)

West Virginia University

A Phase 2 clinical study for patients using Plerixafor

West Virginia University

A clinical research study for the treatment of Hodgkin Lymphoma

West Virginia University Mary Babb Randolf Cancer Center

Patients are needed to participate in a clinical research study evaluating SNS01-T

Lymphoma, B-Cell

GSK Investigational Site

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

Research Site

Patients are needed to participate in a clinical research study to evaluate Diffuse Large B-Cell Lymphoma (DLBCL)

West Virginia University Mary Babb Randolf Cancer Center

Patients are needed to participate in a clinical research study evaluating SNS01-T

Macular Degeneration

Research Site

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Malignant Melanoma

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Mantle Cell Lymphoma

West Virginia University Mary Babb Randolf Cancer Center

Patients are needed to participate in a clinical research study evaluating SNS01-T

Melanoma

West Virginia University - Clinical Trials Research Unit

N0879: A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus for Therapy of Metastatic Malignant Melanoma

West Virginia University - Clinical Trials Research Unit

ECOG 1609 - A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-Risk Melanoma

View More »

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Multiple Myeloma

West Virginia University - Clinical Trials Research Unit

CC-4047-MM-007: A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of Pomalidomide (POM), Bortezomib (BTZ) and Low-Dose Dexamethasone (LD-DEX) versus Bortezomib and Low-Dose Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (MM)

West Virginia University - Clinical Trials Research Unit

PRE1003 A Phase I/II Study of the Tolerability of Lenalidomide and Low Dose Dexamethasone

West Virginia University - Clinical Trials Research Unit

SNS01-T-001 - Phase 1/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma

West Virginia University - Clinical Trials Research Unit

20090482: A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma.

View More »

Celgene Study Site

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma

Mary Babb Randolph Cancer Center/WVU

A Phase 1/Phase 2 clinical study for patients with Multiple Myeloma

Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

West Virginia University

A clinical trial to evaluate treatments using MLN9708 + Lenalidomide + Dexamethasone and Placebo + Lenalidomide + Dexamethasone for patients with Relapsed Multiple Myeloma or Refractory Multiple Myeloma

West Virginia University - Clinical Trials Research Unit

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma

West Virginia University Mary Babb Randolf Cancer Center

Patients are needed to participate in a clinical research study evaluating SNS01-T

WVU - Mary Babb Randolph Cancer Center

A clinical research study of Carfilzomib, proteasome inhibitor; intravenous, ARRY-520, KSP(Eg5) inhibitor; intravenous, Dexamethasone, steroid; oral or intravenous and Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous for the treatment of Advanced Multiple Myeloma

WVU Mary Babb Randolph Cancer Center

A clinical trial to evaluate treatments using Group A=30-60 CrCl (mL/min), Group B=CrCL<30 mL/min not on dialysis and Group C=CrCL<30 mL/min and on dialysis for patients with Multiple Myeloma or Plasma Cell Neoplasm

Multiple Sclerosis

Investigational Site Number 840079 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

United BioSource Corporation

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis, Prenatal Exposure or Pregnancy

Myelodysplastic Syndromes (MDS)

West Virginia University - Clinical Trials Research Unit

E2905: Randomized Phase III Trial Comparing the frequency of Major Erythroid Response to Treatment with Lenolidomide Alone and in Combination with Epoetin Alfa in Subjects with Low or Intermediate 1 Risk MDS and Symptomatic Anemia

Neoplasm Metastasis

Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Neoplasms

Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Research Site

A Phase 1 clinical study for patients with B-cell Malignancies

West Virginia University Healthcare

A Phase 3 clinical study for patients with Colorectal Cancer Metastatic

West Virginia University Mary Babb Randolf Cancer Center

Patients are needed to participate in a clinical research study evaluating SNS01-T

WVU Mary Babb Randolph Cancer Center

A clinical trial to evaluate treatments using Group A=30-60 CrCl (mL/min), Group B=CrCL<30 mL/min not on dialysis and Group C=CrCL<30 mL/min and on dialysis for patients with Multiple Myeloma or Plasma Cell Neoplasm

Nephropathy

Site Reference ID/Investigator# 105201 Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Non-Hodgkin's Lymphoma

West Virginia University - Clinical Trials Research Unit

OMB113603 - An Open-Label Phase I drug-drug interaction study of ofatumumab with bendamustine for the treatment of subjects with indolent B-Cell Non Hodgkin's Lymphoma

West Virginia University - Clinical Trials Research Unit

C14012 - A Phase 3, Randomized, Two-Arm, Open Label, Multicenter, International Trial of Alisertib or Investigator choice in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

West Virginia University - Clinical Trials Research Unit

ECOG1411: Intergroup Randomized, Phase II Four Arm Study in Patients > or equal to 60 with Previously Untreated Mantle Cell Lymphoma

West Virginia University - Clinical Trials Research Unit

MEDI-551-1088 - A Phase 2 Randomized Open-Label Study of MEDI-551 in Adults with Relapsed or Refractory Diffused Large B-Cell Lymphoma

West Virginia University - Clinical Trials Research Unit

S1001 - A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma

West Virginia University - Clinical Trials Research Unit

CALGB50904 - A Randomized Phase II Trial of Ofatumumab and Bendamustine versus Ofatumumab, Bortezomib and Bendamustine in Patients with Untreated Follicular Lymphoma

View More »

GSK Investigational Site

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

West Virginia University

A Phase 2 clinical study for patients using Plerixafor

Non-Small Cell Lung Cancer

West Virginia University - Clinical Trials Research Unit

D1532C00079 - A Phase III, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib in Combination with Docetaxel, in Patients receiving second line treatment for KRAS Mutation-Positive Locally Advanced or Metastatic Non Small Cell Lung Cancer (Stage IIIB – IV) (SELECT-1)

West Virginia University - Clinical Trials Research Unit

WVU010513 - A Phase II Clinical Trial of Image Guided Stereotactic Ablative Radiotherapy SABR) for T2 and microscopic T3 (PL3), N0,M0 Non-small Cell Lung Cancer (NSCLC)

Phenylketonuria

West Virginia Genetics Center, Department of Pediatrics

Patients are needed to participate in a clinical research study of Sapropterin Dihydrochloride to evaluate Phenylketonuria or Hyperphenylalaninaemia

Pompe Disease

Research Site

Patients are needed to participate in a clinical research study evaluating Alglucosidase alfa for the treatment of Pompe Disease

Pregnancy

United BioSource Corporation

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis, Prenatal Exposure or Pregnancy

Pulmonary Arterial Hypertension

West Virginia University Department of Pediatrics

Patients are needed to participate in a clinical research study evaluating observational for the treatment of Pulmonary Arterial Hypertension or Congenital Heart Disease

Rectal Cancer

West Virginia University - Clinical Trials Research Unit

STX0112: Assessment of Overall Survival of FOLFOX6m plus SIR-Spheres microspheres versus FOLFOX6m alone as first-line treatment in patients with non-resectable liver metastases from primary colorectal carcinoma in a randomised clinical study

Stroke

West Virginia University

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Thromboembolism

West Virginia University Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Thrombosis

West Virginia University Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Ulcerative Colitis

Site Reference ID/Investigator# 123082 Updated

A clinical study for patients with Ulcerative Colitis

Ulcers

Site Reference ID/Investigator# 123082 Updated

A clinical study for patients with Ulcerative Colitis

Venous Thromboembolism

West Virginia University Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Venous Thrombosis

West Virginia University Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)